Report - DYNAMO: A PHASE 2 STUDY DEMONSTRATING THE CLINICAL ... · dynamo: a phase 2 study demonstrating the clinical activity of duvelisib in patients with double -refractory indolent non-hodgkin

Please pass captcha verification before submit form